
![]() |
|||||||||||||
WJPR Citation
|
| All | Since 2020 | |
| Citation | 8502 | 4519 |
| h-index | 30 | 23 |
| i10-index | 227 | 96 |
VADE MECUM ON HOLISTIC AND NONPAREIL MANAGEMENT OF THE PERPLEXING QUANDARY OF AMLODIPINE INDUCED GINGIVAL ENLARGEMENT
Dr. Nithiyanandam P.*, Dr. Bhuvaneshwari P., Dr. M. N. Akshaya and Dr. Francisk Donus S.
. Abstract Introduction: Gingival enlargement is a known side effect of calcium channel blockers--especially the dihydropyridine group. It forms a major concern for the patient due to its unesthetic appearance. Objective: To describe the diagnosis and management of amlodipine drug induced gingival enlargement. Materials and Methods: The case presented here is a 50-year-old female patient with drug induced gingival enlargement. Patient was a known hypertensive and was on medication- Amlodipine for past two years. Planned surgical intervention along with comprehensive management was the chosen treatment strategy. Meticulous oral hygiene maintenance, switchover to alternative drug by physician opinion, scaling and root planing and surgical excision of enlarged gingiva in lower anterior, periodontal flap surgery in upper anterior and vestibuloplasty in lower anterior region. Results: The regression and prevention of recurrence of drug-induced gingival overgrowth were achieved through drug substitution, suitable non-surgical and surgical treatment, and excellent plaque control. Post surgical enlargement was found to be minimal, followed by prosthodontic rehabilitation. No recurrence was noted upto a follow up of one year. Conclusion: This case report provides a brief overview of amlodipine induced gingival enlargement and comprehensive management. Keywords: . [Full Text Article] [Download Certificate] |
